<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04698876</url>
  </required_header>
  <id_info>
    <org_study_id>01NVF18002</org_study_id>
    <nct_id>NCT04698876</nct_id>
  </id_info>
  <brief_title>Self Tonometry and Transfer of Glaucoma Patients' Data for Improving the Supply Situation</brief_title>
  <acronym>SALUS</acronym>
  <official_title>SALUS - Selbsttonometrie Und Datentransfer Bei Glaukompatienten Zur Verbesserung Der Versorgungssituation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Muenster</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Federal Joint Committee</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Bielefeld University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fraunhofer Institute for Applied Information Technology FIT</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>KVWL</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>BARMER</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>DAK</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>IKK</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>AOK</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital Muenster</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The SALUS project is developing a new form of care, the application of self-tonometry by the&#xD;
      patient itself, and an accompanying electronic case file connecting clinics, doctor's offices&#xD;
      and patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The SALUS project is developing an outpatient, intersectoral form of care in which patients&#xD;
      measure their intraocular pressure in their home environment with a so-called self-tonometer.&#xD;
      The measured intraocular pressure values are incorporated into daily pressure profiles, which&#xD;
      can be viewed via an electronic case file together with further examination data both by the&#xD;
      treating ophthalmologists in the doctor's offices and clinics and by the patients. The new&#xD;
      form of care not only supports the telemedical networking of doctors but also increases the&#xD;
      compliance by involving the patient in the entire course of the illness.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 11, 2021</start_date>
  <completion_date type="Anticipated">September 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">May 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of observed pressure peaks (&gt;30% of the patient-specific target pressure)</measure>
    <time_frame>7 days (outpatient) or minimum 24 hours (stationary)</time_frame>
    <description>Measurement of intraocular pressure by means of ICareHOME, rebound tonometry or Goldmann applanation tonometry.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of life (patient-oriented)</measure>
    <time_frame>Baseline and after 12 months</time_frame>
    <description>By means of a questionnaire, 0: very bad state of health, 1: best possible state of health</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual field index (VFI)</measure>
    <time_frame>Baseline and after 9 and 12 months</time_frame>
    <description>By means of perimetry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean deviation (MD)</measure>
    <time_frame>Baseline and after 9 and 12 months</time_frame>
    <description>By means of perimetry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pattern standard deviation (PSD)</measure>
    <time_frame>Baseline and after 9 and 12 months</time_frame>
    <description>By means of perimetry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Retinal nerve fiber layer thickness</measure>
    <time_frame>Baseline and after 12 months</time_frame>
    <description>By means of Optical Coherence Tomography (OCT)/ Heidelberg Retina Tomography (HRT)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rim volume</measure>
    <time_frame>Baseline and after 12 months</time_frame>
    <description>By means of Optical Coherence Tomography (OCT)/ Heidelberg Retina Tomography (HRT)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rim area</measure>
    <time_frame>Baseline and after 12 months</time_frame>
    <description>By means of Optical Coherence Tomography (OCT)/ Heidelberg Retina Tomography (HRT)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Systolic and diastolic blood pressure</measure>
    <time_frame>for 24 hours during outpatient and stationary measurements of intraocular pressure</time_frame>
    <description>Long-term blood pressure measurement</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of inpatient and outpatient health services</measure>
    <time_frame>12 month course</time_frame>
    <description>Care provider/ statutory health insurance (SHI) routine data</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Costs of health services</measure>
    <time_frame>12 month course</time_frame>
    <description>Care provider/ SHI routine data</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of periods of incapacity for work (unspecific and diagnosis-specific)</measure>
    <time_frame>12 month course</time_frame>
    <description>Interview/ SHI routine data</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of sick pay days</measure>
    <time_frame>12 month course</time_frame>
    <description>Interview/ SHI routine data</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1980</enrollment>
  <condition>Glaucoma</condition>
  <condition>Intraocular Pressure</condition>
  <condition>Patient Empowerment</condition>
  <condition>Telemedicine</condition>
  <arm_group>
    <arm_group_label>Outpatient measurement of intraocular pressure</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The intervention group measures its intraocular pressure itself in their home environment for 7 days at 6 a.m., 8 a.m., 12 a.m., 4 p.m., 8 p.m. and 12 p.m. with a self-tonometer (iCareHOME).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Stationary measurements of intraocular pressure</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The intraocular pressure of the control group is measured by means of rebound tonometry or Goldmann applanation tonometry in a clinic for minimum 24 hours at 6 a.m., 8 a.m., 12 a.m., 4 p.m., 8 p.m. and 12 p.m.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Self-tonometry by means of ICareHOME</intervention_name>
    <description>Outpatient measurement of intraocular pressure at home</description>
    <arm_group_label>Outpatient measurement of intraocular pressure</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Intraocular measurement by means of rebound tonometry or Goldmann applanation tonometry</intervention_name>
    <description>Stationary measurement of intraocular pressure in a clinic</description>
    <arm_group_label>Stationary measurements of intraocular pressure</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Blood pressure</intervention_name>
    <description>Blood pressure measurement for 24 h</description>
    <arm_group_label>Outpatient measurement of intraocular pressure</arm_group_label>
    <arm_group_label>Stationary measurements of intraocular pressure</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Requirement of a stationary day and night measurement&#xD;
&#xD;
          -  Statutory health insurance&#xD;
&#xD;
          -  Verified and suspicion of glaucoma diagnosis with suspicion of pressure variations and&#xD;
             peaks or not attained target pressure or suspicion of glaucoma progression (H40.1,&#xD;
             H40.2 und H42.-)&#xD;
&#xD;
          -  Willingness for therapy in one of the participating clinics&#xD;
&#xD;
          -  Adequate German language skills&#xD;
&#xD;
          -  Signed and dated informed consent for study participation and data transfer&#xD;
&#xD;
          -  Legal capacity of the insurant to agree to the study participation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients outside the catchment area of the participating clinics&#xD;
&#xD;
          -  Covering illnesses in psychiatry, neurology or other indications (e.g. impairment of&#xD;
             independence) which make self-tonometry impossible&#xD;
&#xD;
          -  Strong communication barriers that do not allow the instruction to carry out the&#xD;
             intervention&#xD;
&#xD;
          -  Unclear legal capacity of the potential study participants&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nicole Eter, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chairholder and Head of the Department of Ophthalmology at the University Hospital Muenster</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kristina Oldiges, Dr.</last_name>
    <phone>+492518359280</phone>
    <email>kristina.oldiges@ukmuenster.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Bielefeld University, Faculty of Public Health, Health Economics and Health Care Management (AG5)</name>
      <address>
        <city>Bielefeld</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wolfgang Greiner, Prof. Dr.</last_name>
      <phone>+49521106156989</phone>
      <email>wolfgang.greiner@uni-bielefeld.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital Muenster</name>
      <address>
        <city>MÃ¼nster</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kristina Oldiges, Dr.</last_name>
      <phone>+492518340500</phone>
      <email>kristina.oldiges@ukmuenster.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>November 25, 2020</study_first_submitted>
  <study_first_submitted_qc>January 4, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 7, 2021</study_first_posted>
  <last_update_submitted>March 29, 2021</last_update_submitted>
  <last_update_submitted_qc>March 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital Muenster</investigator_affiliation>
    <investigator_full_name>Nicole Eter</investigator_full_name>
    <investigator_title>Chairholder and Head of the Department of Ophthalmology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

